UnitedHealthcare Expands Multiple Genetic and Molecular Policies
UnitedHealthcare (UHC) Community Plan’s August policy update revised several medical policies to reflect phase 2 of the DEX® Z-Code requirement for...
1 min read
The U.S. Centers for Medicare & Medicaid Services (CMS) revised the Clinical Laboratory Improvement Amendments of 1988 (CLIA) Post-Public Health Emergency Guidance to discontinue the temporary enforcement discretion allowing for remote review of cytology digital slides.
On Sept. 23, CMS announced it will end the enforcement discretion for remote review of cytology digital slides outside of their primary CLIA-certified cytology laboratory. Any laboratories currently remotely reviewing digital images of cytology slides must obtain a CLIA certificate for that location by March 23, 2026.
In a memo, CMS explains that this enforcement discretion, enacted in response to the COVID-19 pandemic, is no longer necessary. However, CMS will continue to exercise enforcement discretion for laboratory personnel to remotely review digital laboratory data, digital results, and digital images without a separate CLIA certificate for the remote testing site. CMS considers digital materials accessed via a virtual private network to be an extension of the primary laboratory, provided that no microscope or other laboratory equipment is necessary for the review.
Source:
https://www.cms.gov/files/document/qso-23-15-clia-revised-2025-09-23.pdf
CMS Launches IDR Gateway: What Providers Need to Know Before September 15
In late 2026, the Federal Independent Dispute Resolution (IDR) process will transition from single-use web forms to the new IDR Gateway, which will...
Organizations Representing Clinical Labs and Diagnostics Write in Support of Legislation to Improve Medicare LCD Process
A coalition of more than 30 stakeholder organizations has written to key lawmakers expressing their support for the Timely Access to Coverage...